Lauren Riker - 06 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
06 Jun 2023
Net transactions value
-$46,369
Form type
4
Filing time
07 Jun 2023, 21:31:00 UTC
Previous filing
08 Jun 2022
Next filing
16 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $23,044 -591 -2.9% $38.99 19,669 06 Jun 2023 Direct F1, F2
transaction PCRX Common Stock Sale $23,325 -616 -3.1% $37.86 19,053 07 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.